{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:03:10Z","timestamp":1787036590068,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/inf.0b013e31820c1fdf","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T07:06:07Z","timestamp":1296198367000},"page":"570-574","source":"Crossref","is-referenced-by-count":21,"title":["Immunogenicity of Trivalent Influenza Vaccine in Extremely Low-birth-weight, Premature Versus Term Infants"],"prefix":"10.1097","volume":"30","author":[{"given":"Carl T.","family":"D'Angio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy J.","family":"Heyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Duara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Michael","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo J.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Welliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210202","first-page":"27","article-title":"XVI Meeting of the Technical Advisory Group (TAG) on Vaccine-Preventable Diseases of the Pan American Health Organization.","year":"2004"},{"key":"R2-8-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The under-recognized burden of influenza in young children.","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"R3-8-20210202","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/512615","article-title":"Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.","volume":"195","author":"Welliver","year":"2007","journal-title":"J Infect Dis"},{"key":"R4-8-20210202","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1056\/NEJMoa051721","article-title":"Influenza-associated deaths among children in the United States, 2003\u20132004.","volume":"353","author":"Bhat","year":"2005","journal-title":"N Engl J Med"},{"key":"R5-8-20210202","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1542\/peds.113.6.1758","article-title":"Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.","volume":"113","author":"Iwane","year":"2004","journal-title":"Pediatrics"},{"key":"R6-8-20210202","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJM200001273420402","article-title":"Influenza and the rates of hospitalization for respiratory disease among infants and young children.","volume":"342","author":"Izurieta","year":"2000","journal-title":"N Engl J Med"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archpediatrics.2010.195","article-title":"Hospitalization of children with influenza A (H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter survey.","volume":"164","author":"Stein","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R8-8-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archpediatrics.2010.203","article-title":"Children hospitalized with 2009 novel influenza A (H1N1) in California.","volume":"164","author":"Louie","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R9-8-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1542\/peds.2009-2416","article-title":"Annual summary of vital statistics: 2007.","volume":"125","author":"Heron","year":"2010","journal-title":"Pediatrics"},{"key":"R10-8-20210202","first-page":"595","article-title":"Live attenuated and inactivated influenza vaccine in school-age children.","volume":"144","author":"Gruber","year":"1990","journal-title":"Am J Dis Child"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.284.13.1677","article-title":"Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts.","volume":"284","author":"Hurwitz","year":"2000","journal-title":"JAMA"},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1442-200x.2004.01852.x","article-title":"Failure of inactivated influenza A vaccine to protect healthy children aged 6\u201324 months.","volume":"46","author":"Maeda","year":"2004","journal-title":"Pediatr Int"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.vaccine.2005.08.083","article-title":"Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002\u20132003 season.","volume":"24","author":"Fujieda","year":"2006","journal-title":"Vaccine"},{"key":"R14-8-20210202","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children.","author":"Smith","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpedi.162.10.943","article-title":"Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.","volume":"162","author":"Szilagyi","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0264-410X(92)90156-E","article-title":"Immune response to split-product influenza vaccine in preterm and full-term young children.","volume":"10","author":"Groothuis","year":"1992","journal-title":"Vaccine"},{"key":"R17-8-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0264-410X(94)90051-5","article-title":"Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children.","volume":"12","author":"Groothuis","year":"1994","journal-title":"Vaccine"},{"key":"R18-8-20210202","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.vaccine.2005.11.001","article-title":"Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants.","volume":"24","author":"Sasaki","year":"2006","journal-title":"Vaccine"},{"key":"R19-8-20210202","first-page":"69","article-title":"Hsiung's Diagnostic Virology: As Illustrated by Light and Electron Microscopy. 4th ed.","author":"Hsiung","year":"1994"},{"key":"R20-8-20210202","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2010.04.058","article-title":"Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?","volume":"28","author":"Walter","year":"2010","journal-title":"Vaccine"},{"key":"R21-8-20210202","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S0022172400053158","article-title":"Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.","volume":"79","author":"Potter","year":"1977","journal-title":"J Hyg (Lond)"},{"key":"R23-8-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","article-title":"Determinants of immunity to influenza infection in man.","volume":"35","author":"Potter","year":"1979","journal-title":"Br Med Bull"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/01.inf.0000180978.66362.d9","article-title":"Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003\u20132004.","volume":"24","author":"Mitchell","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R25-8-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/infdis\/163.2.300","article-title":"Comparison of heterotypic protection against influenza A\/Taiwan\/86 (H1N1) by attenuated and inactivated vaccines to A\/Chile\/83-like viruses.","volume":"163","author":"Clover","year":"1991","journal-title":"J Infect Dis"},{"key":"R26-8-20210202","first-page":"140","article-title":"Influenza in children: epidemiology, immunity, and vaccines.","volume":"2","author":"Piedra","year":"1991","journal-title":"Semin Pediatr Infect Dis"},{"key":"R27-8-20210202","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1086\/315820","article-title":"Studies of the 1996\u20131997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.","volume":"182","author":"Hurwitz","year":"2000","journal-title":"J Infect Dis"},{"key":"R28-8-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00006454-200108000-00004","article-title":"Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.","volume":"20","author":"Neuzil","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R29-8-20210202","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.vaccine.2009.05.038","article-title":"Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study.","volume":"27","author":"Joshi","year":"2009","journal-title":"Vaccine"},{"key":"R30-8-20210202","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(05)17984-7","article-title":"Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review.","volume":"365","author":"Jefferson","year":"2005","journal-title":"Lancet"},{"key":"R31-8-20210202","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1542\/peds.2004-2258","article-title":"Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.","volume":"116","author":"Piedra","year":"2005","journal-title":"Pediatrics"},{"key":"R32-8-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1542\/peds.2007-3304","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003\u20132004 and 2004\u20132005 influenza seasons.","volume":"122","author":"Eisenberg","year":"2008","journal-title":"Pediatrics"},{"key":"R33-8-20210202","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e3181b0c0ca","article-title":"Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.","volume":"28","author":"Walter","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R34-8-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/INF.0b013e3181b84c34","article-title":"Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.","volume":"29","author":"Englund","year":"2010","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201107000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:51:55Z","timestamp":1786042315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201107000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31820c1fdf","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}